Needham’s Matson, Saxon break down the Abbott-CSI and Globus-Nuvasive deals. Is more M&A on the way?
The weekend ended with a bang as Abbott and Globus Medical both announced significant deals. Abbott picked up publicly traded Cardiovascular Solutions for $890 million while Globus Medical acquired – or merged if you prefer – with publicly held spine competitor NuVasive in a deal valued more than $3 billion.
In this week’s episode, host Tom Salemi explores each deal with Wall Street Analysts Mike Matson and David Saxon from Needham. The conversation begins with the big question – Is this this start of a robust year for M&A.
Executive Editor Chris Newmarker also delivers his Newmarker’s Newsmakers. Abbott, CSI, Globus, and NuVasive top the list along with GE Healthcare’s acquisition of Caption Health. Other medtech companies making the vaunted list include 3M, Dexcom, Ethicon, and Inspire Medical.
This episode is sponsored by DeviceTalks Boston. Go to DeviceTalks.com to find out more information about our upcoming in-person conference.
Thanks for listening to this episode of DeviceTalks Weekly.
You can subscribe this podcast on any major podcast player.
In this week’s episode, host Tom Salemi explores each deal with Wall Street Analysts Mike Matson and David Saxon from Needham. The conversation begins with the big question – Is this this start of a robust year for M&A.
Executive Editor Chris Newmarker also delivers his Newmarker’s Newsmakers. Abbott, CSI, Globus, and NuVasive top the list along with GE Healthcare’s acquisition of Caption Health. Other medtech companies making the vaunted list include 3M, Dexcom, Ethicon, and Inspire Medical.
This episode is sponsored by DeviceTalks Boston. Go to DeviceTalks.com to find out more information about our upcoming in-person conference.
Thanks for listening to this episode of DeviceTalks Weekly.
You can subscribe this podcast on any major podcast player.
Activity